|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Reconciliation of net income to net cash provided by operating activities: | |||||
| Income from discontinued operations, net of tax | |||||
| Depreciation and amortization | |||||
| (Gains)/losses on asset sales, asset impairments and other, net (Note 7, Note 8) | |||||
| Equity-indexed compensation expense | |||||
| Inventory valuation adjustments (Note 5) | |||||
| Deferred income tax expense | |||||
| Gains on sales of linefill | |||||
| (Gain)/loss on foreign currency revaluation | |||||
| Settlement of terminated interest rate hedging instruments (Note 13) | |||||
| Change in fair value of Preferred Distribution Rate Reset Option (Note 13) | |||||
| Equity earnings in unconsolidated entities | |||||
| Distributions on earnings from unconsolidated entities | |||||
| Gain on investments in unconsolidated entities, net (Note 8, Note 9) | |||||
| Other | |||||
| Changes in assets and liabilities, net of acquisitions: | |||||
| Trade accounts receivable and other | |||||
| Inventory | |||||
| Trade accounts payable and other | |||||
| Cash provided by operating activities - continuing operations | |||||
| Cash provided by operating activities - discontinued operations | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Cash paid in connection with acquisitions, net of cash acquired (Note 8) | |||||
| Investments in unconsolidated entities (Note 9) | |||||
| Additions to property, equipment and other | |||||
| Cash paid for purchases of linefill | |||||
| Proceeds from sales of assets (Note 8) | |||||
| Cash received from sales of linefill | |||||
| Other investing activities | |||||
| Cash used in investing activities - continuing operations | |||||
| Cash used in investing activities - discontinued operations | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Net borrowings/(repayments) under PAA commercial paper program (Note 11) | |||||
| Repayment under PAA EPIC credit agreement (Note 11) | |||||
| Borrowing under PAA term loan (Note 11) | |||||
| Proceeds from the issuance of PAA senior notes (Note 11) | |||||
| Repayments of PAA senior notes (Note 11) | |||||
| Repurchase of common units by a subsidiary (Note 12) | |||||
| Repurchase of Series A preferred units by a subsidiary (Note 12) | |||||
| Distributions paid to Class A shareholders (Note 12) | |||||
| Distributions paid to noncontrolling interests (Note 12) | |||||
| Contributions from noncontrolling interests | |||||
| Other financing activities | |||||
| Net cash provided by/(used in) financing activities | |||||
| Effect of translation adjustment - continuing operations | |||||
| Effect of translation adjustment - discontinued operations | |||||
| Net increase/(decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Cash paid for: | |||||
| Interest, net of amounts capitalized | |||||
| Income taxes, net of amounts refunded (Note 15) | |||||
Loading...